nach oben

Inflammation

Erschienen in:

26.06.2023 | RESEARCH

Bavachinin Ameliorates Rheumatoid Arthritis Inflammation via PPARG/PI3K/AKT Signaling Pathway

verfasst von: Hui Deng, Jing Jiang, Jie Shu, Meng Huang, Qing-Lian Zhang, Li-Juan Wu, Wen-Kui Sun

Erschienen in: Inflammation | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Bavachinin (BVC) is a natural small molecule from the Chinese herb Fructus Psoraleae. It exhibits numerous pharmacological effects, including anti-cancer, anti-inflammation, anti-oxidation, anti-bacterial, anti-viral, and immunomodulatory properties. BVC may serve as a novel drug candidate for the treatment of rheumatoid arthritis (RA). Nevertheless, the effects and mechanisms of BVC against RA are still unknown. BVC targets were selected by Swiss Target Prediction and the PharmMapper database. RA-related targets were collected from the GeneCards, OMIM, DrugBank, TTD, and DisGeNET databases. PPI network construction and enrichment analysis were conducted by taking the intersection target of BVC targets and RA-related targets. Hub targets were further screened using Cytoscape and molecular docking. MH7A cell lines and collagen‐induced arthritis (CIA) mice were used to confirm the preventive effect of BVC on RA and its potential mechanism. Fifty-six RA-related targets of BVC were identified through databases. These genes were primarily enriched in PI3K/AKT signaling pathway according to KEGG enrichment analysis. Molecular docking analysis suggested that BVC had the highest binding energy with PPARG. The qPCR and western blotting results showed that BVC promoted the expression of PPARG at both the mRNA level and protein level. Western blotting indicated that BVC might affect MH7A cell functions through the PI3K/AKT pathway. Furthermore, treatment with BVC inhibited the proliferation, migration, and production of inflammatory cytokines in MH7A cells and induced cell apoptosis to a certain extent. In vivo, BVC alleviated joint injury and inflammatory response in CIA mice. This study revealed that BVC may inhibit the proliferation, migration, and production of inflammatory cytokines in MH7A cells, as well as cell apoptosis through the PPARG/PI3K/AKT signaling pathway. These findings provide a theoretical foundation for RA therapy.

Nur mit Berechtigung zugänglich

McInnes, I., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. The New England journal of medicine. 365 (23): 2205–2219. https://doi.org/10.1056/NEJMra1004965.CrossRefPubMed

Singh, J., D. Furst, A. Bharat, et al. 2012. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis care & research. 64 (5): 625–639. https://doi.org/10.1002/acr.21641.CrossRef

Smolen, J., R. Landewé, F. Breedveld, et al. 2014. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Annals of the Rheumatic Diseases 73 (3): 492–509. https://doi.org/10.1136/annrheumdis-2013-204573.CrossRefPubMed

Lee, D., and M. Weinblatt. 2001. Rheumatoid arthritis. Lancet (London, England). 358 (9285): 903–911. https://doi.org/10.1016/s0140-6736(01)06075-5.CrossRefPubMed

Xu, H., S. Zheng, and D. Fox. 2020. Editorial: Immunomodulatory functions of fibroblast-like synoviocytes in joint inflammation and destruction during rheumatoid arthritis. Frontiers in Immunology 11: 955. https://doi.org/10.3389/fimmu.2020.00955.CrossRefPubMedPubMedCentral

Bottini, N., and G. Firestein. 2013. Duality of fibroblast-like synoviocytes in RA: Passive responders and imprinted aggressors. Nature Reviews Rheumatology 9 (1): 24–33. https://doi.org/10.1038/nrrheum.2012.190.CrossRefPubMed

Falconer, J., A. Murphy, S. Young, et al. 2018. Review: Synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis & Rhematology 70 (7): 984–999. https://doi.org/10.1002/art.40504.CrossRef

Samarpita, S., R. Ganesan, and M. Rasool. 2020. Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis. Toxicology and Applied Pharmacology 391: 114917. https://doi.org/10.1016/j.taap.2020.114917.

Ma, J.-D., J. Jing, J.W. Wang, et al. 2019. A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Research and Therapy 21 (1). https://doi.org/10.1186/s13075-019-1935-6.

10.

Gan, D., W. Cheng, L. Ke, et al. 2021. Taraxasterol suppresses inflammation in IL-1beta-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice. Frontier Pharmacology 12: 631891. https://doi.org/10.3389/fphar.2021.631891.

11.

Meng, M., Z. Yue, L. Chang, et al. 2021. Anti-rheumatoid arthritic effects of Paris saponin VII in human rheumatoid arthritis fibroblast-like synoviocytes and adjuvant-induced arthritis in rats. Frontier Pharmacology 12: 683698. https://doi.org/10.3389/fphar.2021.683698.

12.

Commission, C.P. 2015. Chinese Pharmacopoeia (2015, VolumeI), 187. Beijing: Chinese Medicine Science and Technology Press.

13.

Zhou, Y.-T., L. Zhu, Y. Yuan, et al. 2020. Effects and mechanisms of five Psoralea prenylflavonoids on aging-related diseases. Oxidative Medicine and Cellular Longevity. 2020: 2128513. https://doi.org/10.1155/2020/2128513.CrossRefPubMedPubMedCentral

14.

Chen, Q., Y. Li, and Z. Chen. 2012. Separation, identification, and quantification of active constituents in by high-performance liquid chromatography with UV, ion trap mass spectrometry, and electrochemical detection. J Pharm Anal. 2 (2): 143–151. https://doi.org/10.1016/j.jpha.2011.11.005.CrossRefPubMed

15.

Chen, X., Y. Yang, and Y. Zhang. 2013. Isobavachalcone and bavachinin from Psoraleae Fructus modulate Aβ42 aggregation process through different mechanisms in vitro. FEBS Letters. 587 (18): 2930–2935. https://doi.org/10.1016/j.febslet.2013.07.037.CrossRefPubMed

16.

Hung, S.-Y., S.-C. Lin, S. Wang, et al. 2021. Bavachinin induces G2/M cell cycle arrest and apoptosis via the ATM/ATR signaling pathway in human small cell lung cancer and shows an antitumor effect in the xenograft model. Journal of Agricultural and Food Chemistry. 69 (22): 6260–6270. https://doi.org/10.1021/acs.jafc.1c01657.CrossRefPubMed

17.

Matsuda, H., S. Kiyohara, S. Sugimoto, et al. 2009. Bioactive constituents from Chinese natural medicines. XXXIII. Inhibitors from the seeds of Psoralea corylifolia on production of nitric oxide in lipopolysaccharide-activated macrophages. Biological and Pharmaceutical Bulletin 32 (1): 147–149.

18.

Nepal, M., H.J. Choi, B.-Y. Choi, et al. 2012. Anti-angiogenic and anti-tumor activity of bavachinin by targeting hypoxia-inducible factor-1α. European Journal of Pharmacology. 691 (1–3): 28–37. https://doi.org/10.1016/j.ejphar.2012.06.028.CrossRefPubMed

19.

Pai, J.-T., M.W. Hsu, Y.L. Leu, et al. 2021. Induction of G2/M cell cycle arrest via p38/p21-dependent signaling pathway activation by bavachinin in non-small-cell lung cancer cells. Molecules 26 (17). https://doi.org/10.3390/molecules26175161.

20.

Zhao, C., B. Ghosh, T. Chakraborty, et al. 2021. Bavachinin mitigates DMH induced colon cancer in rats by altering p53/Bcl2/BAX signaling associated with apoptosis. Biotechnic & histochemistry : Official publication of the Biological Stain Commission. 96 (3): 179–190. https://doi.org/10.1080/10520295.2020.1778087.CrossRef

21.

Chen, X., T. Wen, J. Wei, et al. 2013. Treatment of allergic inflammation and hyperresponsiveness by a simple compound, bavachinin, isolated from Chinese herbs. Cellular & Molecular Immunology. 10 (6): 497–505. https://doi.org/10.1038/cmi.2013.27.CrossRef

22.

Poornima, P., J.D. Kumar, Q. Zhao, et al. 2016. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature. Pharmacological Research. 111: 290–302. https://doi.org/10.1016/j.phrs.2016.06.018.CrossRefPubMed

23.

Yang, S., J. Zhang, Y. Yan, et al. 2019. Network pharmacology-based strategy to investigate the pharmacologic mechanisms of Koidz. for the Treatment of Chronic Gastritis. Frontier Pharmacology 10, 1629. https://doi.org/10.3389/fphar.2019.01629.

24.

Hopkins, A.L. 2008. Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology 4 (11): 682–690. https://doi.org/10.1038/nchembio.118.CrossRefPubMed

25.

Kim, S., J. Chen, T. Cheng, et al. 2021. PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Research 49 (D1): D1388–D1395. https://doi.org/10.1093/nar/gkaa971.CrossRefPubMed

26.

Daina, A., O. Michielin, and V. Zoete. 2019. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research 47 (W1): W357–W364. https://doi.org/10.1093/nar/gkz382.CrossRefPubMedPubMedCentral

27.

Wang, X., Y. Shen, S. Wang, et al. 2017. PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Research 45 (W1): W356–W360. https://doi.org/10.1093/nar/gkx374.CrossRefPubMedPubMedCentral

28.

Rappaport, N., M. Twik, I. Plaschkes, et al. 2017. MalaCards: An amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Research 45 (D1): D877–D887. https://doi.org/10.1093/nar/gkw1012.CrossRefPubMed

29.

Wishart, D. S., Y.D. Feunang, A.C. Guo, et al. 2018. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research 46 (D1): D1074–D1082. https://doi.org/10.1093/nar/gkx1037.

30.

Zhou, Y., Y. Zhang, X. Lian, et al. 2022. Therapeutic target database update 2022: Facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Research 50 (D1): D1398–D1407. https://doi.org/10.1093/nar/gkab953.CrossRefPubMed

31.

Piñero, J., J.M. Ramírez-Anguita, J. Saüch-Pitarch, et al. 2020. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Research 48 (D1): D845–D855. https://doi.org/10.1093/nar/gkz1021.CrossRefPubMed

32.

UniProt: the universal protein knowledgebase in 2021. 2021. Nucleic Acids Research 49 (D1): D480–D489. https://doi.org/10.1093/nar/gkaa1100.

33.

Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423 (6937): 356–361. https://doi.org/10.1038/nature01661.CrossRefPubMed

34.

Bartok, B., and G.S. Firestein. 2010. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunological Reviews 233 (1): 233–255. https://doi.org/10.1111/j.0105-2896.2009.00859.x.CrossRefPubMedPubMedCentral

35.

Filer, A., L.S.C. Ward, S. Kemble, et al. 2017. Identification of a transitional fibroblast function in very early rheumatoid arthritis. Annals of the Rheumatic Diseases 76 (12): 2105–2112. https://doi.org/10.1136/annrheumdis-2017-211286.CrossRefPubMed

36.

Zhang, L.-M., J.J. Zhou and C.L. Luo. 2018. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation. Arthritis Research and Therapy 20 (1): 219. https://doi.org/10.1186/s13075-018-1722-9.

37.

Zhu, S.-L., J.-L. Huang, W.-X. Peng, et al. 2017. Inhibition of smoothened decreases proliferation of synoviocytes in rheumatoid arthritis. Cellular & Molecular Immunology. 14 (2): 214–222. https://doi.org/10.1038/cmi.2015.67.CrossRef

38.

Leverson, J. D., D.C. Phillips, M.J. Mitten, et al. 2015. Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Science Translational Medicine 7 (279): 279ra40. https://doi.org/10.1126/scitranslmed.aaa4642.

39.

Mahajan, S.D., V.M. Tutino, Y. Redae, et al. 2016. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology 148 (4): 407–419. https://doi.org/10.1111/imm.12619.CrossRefPubMedPubMedCentral

40.

Tsuruta, F., N. Masuyama, and Y. Gotoh. 2002. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. Journal of Biological Chemistry 277 (16): 14040–14047. https://doi.org/10.1074/jbc.M108975200.CrossRefPubMed

41.

Carneiro, B.A., and W.S. El-Deiry. 2020. Targeting apoptosis in cancer therapy. Nature Reviews. Clinical Oncology 17 (7): 395–417. https://doi.org/10.1038/s41571-020-0341-y.CrossRefPubMedPubMedCentral

42.

Pickens, S.R., M.V. Volin, A.M. Mandelin, et al. 2010. IL-17 contributes to angiogenesis in rheumatoid arthritis. The Journal of Immunology 184 (6): 3233–3241. https://doi.org/10.4049/jimmunol.0903271.CrossRefPubMed

43.

Brennan, F.M., and I.B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. The Journal of Clinical Investigation 118 (11): 3537–3545. https://doi.org/10.1172/JCI36389.CrossRefPubMedPubMedCentral

44.

Davignon, J.-L., B. Rauwel, Y. Degboé, et al. 2018. Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review. Arthritis Research and Therapy 20 (1): 229. https://doi.org/10.1186/s13075-018-1725-6.

45.

Sur, B., S. Kang, M. Kim, et al. 2019. Inhibition of carrageenan/kaolin-induced arthritis in rats and of inflammatory cytokine expressions in human IL-1β-stimulated fibroblast-like synoviocytes by a benzylideneacetophenone derivative. Inflammation 42 (3): 928–936. https://doi.org/10.1007/s10753-018-0947-8.CrossRefPubMed

46.

Ruderman, E.M. 2015. Rheumatoid arthritis: IL-6 inhibition in RA–déjà vu all over again? Nature Reviews Rheumatology 11 (6): 321–322. https://doi.org/10.1038/nrrheum.2015.58.CrossRefPubMed

47.

Mitchell, J., S.J. Kim, G. Koukos, et al. 2018. Colonic inhibition of phosphatase and tensin homolog increases colitogenic bacteria, causing development of colitis in Il10-/- mice. Inflammatory Bowel Diseases 24 (8): 1718–1732. https://doi.org/10.1093/ibd/izy124.CrossRefPubMedPubMedCentral

48.

Borges, G.R., D.A. Morgan, P. Ketsawatsomkron, et al. 2014. Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction. Hypertension 64 (3): 590–596. https://doi.org/10.1161/HYPERTENSIONAHA.114.03553.CrossRefPubMed

49.

Pestereva, E., S. Kanakasabai, and J.J. Bright. 2012. PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells. British Journal of Cancer 106 (10): 1702–1712. https://doi.org/10.1038/bjc.2012.161.CrossRefPubMedPubMedCentral

50.

Li, X.-F., Y.Y. Sun, J. Bao, et al. 2017. Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. Scientific Reports 7 (1): 12671. https://doi.org/10.1038/s41598-017-12570-6.

51.

Li, X.-F., S.-Q. Yin, H. Li, et al. 2022. PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis. Acta Pharmacologica Sinica. https://doi.org/10.1038/s41401-022-00957-9.CrossRefPubMedPubMedCentral

52.

Yang, H., Y. Luo, and X. Lai. 2022. Il-34 regulates MAPKs, PI3K/Akt, JAK and NF-κB pathways and induces the expression of inflammatory factors in RA-FLS. Clinical and Experimental Rheumatology 40 (9): 1779–1788. https://doi.org/10.55563/clinexprheumatol/6t1d4i.

53.

Li, X., and Y. Wang. 2020. Cinnamaldehyde attenuates the progression of rheumatoid arthritis through down-regulation of PI3K/AKT signaling pathway. Inflammation 43 (5): 1729–1741. https://doi.org/10.1007/s10753-020-01246-5.CrossRefPubMed

Titel: Bavachinin Ameliorates Rheumatoid Arthritis Inflammation via PPARG/PI3K/AKT Signaling Pathway
verfasst von: Hui Deng
Jing Jiang
Jie Shu
Meng Huang
Qing-Lian Zhang
Li-Juan Wu
Wen-Kui Sun
Publikationsdatum: 26.06.2023
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 5/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-023-01855-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Bavachinin Ameliorates Rheumatoid Arthritis Inflammation via PPARG/PI3K/AKT Signaling Pathway

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2023

Glipizide Alleviates Periodontitis Pathogenicity via Inhibition of Angiogenesis, Osteoclastogenesis and M1/M2 Macrophage Ratio in Periodontal Tissue

Lymphocyte-Specific Protein Tyrosine Kinase Contributes to Spontaneous Regression of Liver Fibrosis may by Interacting with Suppressor of Cytokine Signaling 1

Circular RNA CircDHRS3 Aggravates IL-1β-induced ECM Degradation, Apoptosis, and Inflammatory Response via Mediating MECP2 Expression

Small Extracellular Vesicles from Periodontal Ligament Stem Cells Primed by Lipopolysaccharide Regulate Macrophage M1 Polarization via miR-433-3p Targeting TLR2/TLR4/NF-κB

The Increased TIGIT-Expressing CD3+CD56+ Cells Are Associated with Coronary Artery Disease and Its Inflammatory Environment

Role of Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) in Immune and Inflammatory Diseases

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin